Immune restoration diseases reflect diverse immunopathological mechanisms

QR Code

Immune restoration diseases reflect diverse immunopathological mechanisms

Bibliographic Details
Main Authors:	Price, Patricia, Murdoch, D., Agarwal, U., Lewin, S., Elliott, J., French, M.
Format:	Journal Article
Published:	2009
Online Access:	http://hdl.handle.net/20.500.11937/14460

Similar Items

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

Mycobacterial immune restoration disease: One symphony, two or many?
by: Price, Patricia
Published: (2012)

The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis
by: Affandi, J., et al.
Published: (2013)

Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease
by: Lim, A., et al.
Published: (2008)

Interferon-? and IL-5 production correlate directly in HIV patients Co-infected with mycobacterium tuberculosis with or without immune restoration disease
by: Oliver, B., et al.
Published: (2010)

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

Increased plasma CXCL10 may be a marker of increased risk of immune restoration disease associated with nonviral pathogens
by: Oliver, B., et al.
Published: (2012)

Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia
by: Sumatoh, H., et al.
Published: (2011)

Characteristics of natural killer cells in Malaysian HIV patients presenting with immune restoration disease after ART
by: Tan, D., et al.
Published: (2010)

Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis
by: Tan, D., et al.
Published: (2008)

Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis
by: Price, Patricia, et al.
Published: (2012)

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease
by: Tan, D., et al.
Published: (2011)

Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation
by: Agarwal, U., et al.
Published: (2012)

Plasma biomarkers in the prediction and diagnosis of tuberculosis-associated immune reconstitution inflammatory syndrome
by: French, M., et al.
Published: (2011)

Immune reconstitution syndrome is not a single entity
by: Price, Patricia, et al.
Published: (2008)

Bursal immunopathology responses of specific-pathogen-free chickens and red jungle fowl infected with very virulent infectious bursal disease virus
by: Omar, Abdul Rahman, et al.
Published: (2018)

Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART
by: Yunihastuti, E., et al.
Published: (2011)

Maintaining and restoring diversity
by: Majer, Jonathan
Published: (1992)

Can immune-related genotypes illuminate the immunopathogenesis of cytomegalovirus disease in human immunodeficiency virus-infected patients?
by: Affandi, J., et al.
Published: (2012)

Optimising Elite Athlete Stress Regulation via Systematic Reflections of Stressor Events
by: Murdoch, Elizabeth M.
Published: (2024)

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy
by: Lim, A., et al.
Published: (2009)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

The immune response of maternally immune chickens vaccinated with the Australian V4 Newcastle disease vaccine
by: Ibrahim, A. Latif, et al.
Published: (1982)

Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura
by: Gardiner, E., et al.
Published: (2010)

Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD)
by: Tan, D., et al.
Published: (2014)

TNF block haplotypes reveal diverse pathways between TNF and disease: Implications for understanding neuropathy in HIV patients
by: Chew, C., et al.
Published: (2012)

Rainforest restoration for biodiversity and the production of timber
by: Wardell-Johnson, Grant, et al.
Published: (2008)

Can immunogenetics illuminate the diverse manifestations of respiratory infections?
by: Affandi, J., et al.
Published: (2010)

Vaccine justice and bioethical reflections of COVID-19 immunization in Malaysia
by: Moorthy, Ravichandran, et al.
Published: (2022)

Evaluating the immunopathological effects of nigella sativa oil and its major component, thymoquinone in a streptozotocin-induces type1 diabetes rat model / Afaf Jamal Ali Hmza
by: Ali Hmza, Afaf Jamal
Published: (2013)

Increased CTLA-4+ T cells may contribute to impaired T helper type 1 immune responses in patients with chronic obstructive pulmonary disease
by: Tan, D., et al.
Published: (2017)

Susceptibility to pulmonary disease due to Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiency
by: Lim, A., et al.
Published: (2010)

Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
by: Oliver, B., et al.
Published: (2012)

Immunosenescent CD57 +CD4+ T-cells accumulate and contribute to interferon-γ responses in HIV patients responding stably to ART
by: Fernandez, S., et al.
Published: (2011)

Seed production areas for the global restoration challenge
by: Nevill, Paul, et al.
Published: (2016)

Expansion of adaptive NK cells in HIV disease persists following combination antiretroviral therapy
by: Hearps, A., et al.
Published: (2016)

HIV patients stable on ART retain evidence of a high CMV load but changes to Natural Killer cell phenotypes reflect both HIV and CMV
by: Affandi, J., et al.
Published: (2015)

Improving function of older people receiving a restorative care service
by: Burton, Elissa, et al.
Published: (2012)

Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
by: Tan, D., et al.
Published: (2009)